Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPEP8 is a **pseudogene** related to the "small nuclear ribonucleoprotein polypeptide E" (SNRPE) gene. Pseudogenes are DNA sequences similar to normal genes but are non-functional due to mutations or lack of regulatory elements, meaning they do not encode an active protein or functional RNA. SNRPEP8 does not encode an expressed or active gene product and is not implicated in any known biological process or disease[5][2]. Additional context: The canonical, functional SNRPE gene encodes a core component of the spliceosome complex involved in pre-mRNA splicing[1][3]. Several pseudogenes exist for SNRPE, including SNRPEP8[3]. Pseudogenes may occasionally be transcribed as non-coding RNAs (e.g., lncRNAs), but there is no evidence SNRPEP8 plays such a role[5][2]. SNRPEP8 appears in gene catalogs for completeness but is not used as a therapeutic target, disease marker, or drug discovery entity[5][2]. Summary: SNRPEP8 is a non-coding pseudogene, not a valid therapeutic or molecular target. Any reference to SNRPEP8 as a receptor, enzyme, or druggable protein would be incorrect or misleading.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide E pseudogene 8 (SNRPEP8).